oral tirzepatide clinical trial trials of subcutaneous (SURMOUNT-1, -2 and -3 Tirzepatide Oral Sublingual Tablets in

A subgroup of patients using the GLP-1 tirzepatide experience nearly twice the improvement in sleep apnea severity.

In this Review, Cowie and Fisher describe the additional mechanisms of benefit of SGLT2 inhibitors, unrelated to improved glycaemic control.

Researchers use real-world data in the United States to evaluate the protective role of semaglutide against Alzherimers disease.

AT THE ADA ANNUAL SCIENTIFIC SESSIONS NEW ORLEANS (FRONTLINE MEDICAL NEWS) Semaglutide, a GLP-1 agonist for type 2 diabetes thats dosed weekly, was superior to daily sitagliptin in improving glycemic control and reducing body weight in people who are also on metformin and/or thiazolidinediones (TZDs), based on results from

Specifically formulated for GLP-1 users

Discover why weight loss plateaus occur with semaglutide and liraglutide, what the evidence shows about long-term effectiveness, and practical strategies to maintain treatment benefits for diabetes and weight management.